i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

May 21, 2024

Time to read 4 Minutes

Download PDF

Back